Examedi, Chilean healthtech, revolutionizes health with AI and expands its services
In recent years, Chilean healthtech Examedi has emerged as a critical player in the health sector, especially during the pandemic. Initially, Examedi focused on offering at-home PCR tests, an innovation directly dependent on the COVID-19 context. Despite challenges, Examedi secured a significant USD$17 million in its Series A funding, allowing it to diversify and expand its health services. The company, founded by Chileans, has evolved to integrate various new services. These include telemedicine, kinesiology, therapeutic massages, nutrition, and mental health.